Hagerty Research Development vs Tax Provision Analysis

HGTY Stock

USD 11.04 0.09 0.81%

Hagerty financial indicator trend analysis is much more than just examining Hagerty latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Hagerty is a good investment. Please check the relationship between Hagerty Research Development and its Tax Provision accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hagerty. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Hagerty Stock please use our How to Invest in Hagerty guide.

Research Development vs Tax Provision

Research Development vs Tax Provision Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Hagerty Research Development account and Tax Provision. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Hagerty's Research Development and Tax Provision is -0.56. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Tax Provision in the same time period over historical financial statements of Hagerty, assuming nothing else is changed. The correlation between historical values of Hagerty's Research Development and Tax Provision is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Hagerty are associated (or correlated) with its Tax Provision. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Tax Provision has no effect on the direction of Research Development i.e., Hagerty's Research Development and Tax Provision go up and down completely randomly.

Correlation Coefficient

-0.56

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Research Development

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Most indicators from Hagerty's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Hagerty current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hagerty. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Hagerty Stock please use our How to Invest in Hagerty guide.At this time, Hagerty's Issuance Of Capital Stock is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 0.41 in 2024, whereas Tax Provision is likely to drop slightly above 7.5 M in 2024.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	22.1M	33.9M	45.8M	23.9M
Tax Provision	6.8M	7.0M	14.9M	7.5M

Depreciation And Amortization Tax Provision

Hagerty fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Deferred Long Term Liab
Common Stock Shares Outstanding		0.9	0.87	0.87	0.9	0.17	0.05	-0.23	0.95	-0.76	-0.51	0.86	0.63	-0.22	-0.58	0.87	0.26	0.33	-0.63	0.92	0.92	-0.6	0.97	0.9	0.88	0.74
Total Assets	0.9		0.98	0.99	0.69	-0.16	0.43	0.18	0.88	-0.91	-0.68	0.84	0.8	0.01	-0.45	0.95	0.49	0.69	-0.8	0.89	0.97	-0.85	0.87	0.93	1.0	0.92
Short Long Term Debt Total	0.87	0.98		0.98	0.63	-0.24	0.48	0.21	0.92	-0.91	-0.57	0.83	0.72	-0.13	-0.58	0.93	0.62	0.72	-0.81	0.88	0.99	-0.78	0.8	0.91	0.99	0.92
Other Current Liab	0.87	0.99	0.98		0.67	-0.17	0.45	0.19	0.86	-0.88	-0.69	0.87	0.8	0.04	-0.41	0.93	0.51	0.7	-0.76	0.87	0.97	-0.85	0.85	0.9	1.0	0.95
Total Current Liabilities	0.9	0.69	0.63	0.67		0.56	-0.35	-0.58	0.78	-0.41	-0.49	0.86	0.55	-0.07	-0.33	0.69	-0.11	-0.05	-0.25	0.81	0.72	-0.43	0.94	0.74	0.67	0.58
Total Stockholder Equity	0.17	-0.16	-0.24	-0.17	0.56		-0.93	-0.87	0.03	0.43	-0.13	0.22	0.06	0.15	0.23	-0.02	-0.81	-0.78	0.5	0.19	-0.12	0.18	0.29	0.06	-0.19	-0.23
Other Liab	0.05	0.43	0.48	0.45	-0.35	-0.93		0.92	0.15	-0.64	-0.24	0.04	0.3	0.09	-0.16	0.32	0.79	0.94	-0.68	0.09	0.36	-0.52	-0.03	0.23	0.46	0.49
Net Tangible Assets	-0.23	0.18	0.21	0.19	-0.58	-0.87	0.92		-0.12	-0.45	-0.22	-0.25	0.24	0.25	0.08	0.15	0.57	0.83	-0.56	-0.08	0.08	-0.43	-0.28	0.06	0.2	0.2
Property Plant And Equipment Net	0.95	0.88	0.92	0.86	0.78	0.03	0.15	-0.12		-0.79	-0.38	0.84	0.55	-0.38	-0.75	0.87	0.46	0.42	-0.68	0.91	0.95	-0.55	0.85	0.9	0.88	0.76
Current Deferred Revenue	-0.76	-0.91	-0.91	-0.88	-0.41	0.43	-0.64	-0.45	-0.79		0.57	-0.56	-0.7	0.09	0.52	-0.88	-0.61	-0.83	0.97	-0.78	-0.86	0.8	-0.68	-0.86	-0.91	-0.75
Net Debt	-0.51	-0.68	-0.57	-0.69	-0.49	-0.13	-0.24	-0.22	-0.38	0.57		-0.55	-0.98	-0.69	-0.29	-0.76	0.1	-0.47	0.52	-0.68	-0.55	0.93	-0.65	-0.71	-0.67	-0.6
Accounts Payable	0.86	0.84	0.83	0.87	0.86	0.22	0.04	-0.25	0.84	-0.56	-0.55		0.66	-0.01	-0.37	0.79	0.28	0.31	-0.38	0.83	0.89	-0.62	0.86	0.79	0.85	0.89
Cash	0.63	0.8	0.72	0.8	0.55	0.06	0.3	0.24	0.55	-0.7	-0.98	0.66		0.54	0.09	0.87	0.06	0.56	-0.63	0.8	0.7	-0.97	0.72	0.83	0.79	0.71
Non Current Assets Total	-0.22	0.01	-0.13	0.04	-0.07	0.15	0.09	0.25	-0.38	0.09	-0.69	-0.01	0.54		0.88	0.07	-0.44	0.11	0.1	-0.03	-0.16	-0.49	0.01	-0.01	0.0	0.08
Non Currrent Assets Other	-0.58	-0.45	-0.58	-0.41	-0.33	0.23	-0.16	0.08	-0.75	0.52	-0.29	-0.37	0.09	0.88		-0.4	-0.64	-0.25	0.49	-0.46	-0.59	-0.03	-0.36	-0.45	-0.46	-0.34
Other Assets	0.87	0.95	0.93	0.93	0.69	-0.02	0.32	0.15	0.87	-0.88	-0.76	0.79	0.87	0.07	-0.4		0.34	0.61	-0.81	0.97	0.93	-0.87	0.85	0.99	0.95	0.81
Long Term Debt	0.26	0.49	0.62	0.51	-0.11	-0.81	0.79	0.57	0.46	-0.61	0.1	0.28	0.06	-0.44	-0.64	0.34		0.78	-0.59	0.21	0.55	-0.26	0.07	0.29	0.53	0.59
Cash And Short Term Investments	0.33	0.69	0.72	0.7	-0.05	-0.78	0.94	0.83	0.42	-0.83	-0.47	0.31	0.56	0.11	-0.25	0.61	0.78		-0.84	0.41	0.62	-0.74	0.26	0.53	0.71	0.69
Net Receivables	-0.63	-0.8	-0.81	-0.76	-0.25	0.5	-0.68	-0.56	-0.68	0.97	0.52	-0.38	-0.63	0.1	0.49	-0.81	-0.59	-0.84		-0.69	-0.74	0.74	-0.54	-0.79	-0.8	-0.6
Good Will	0.92	0.89	0.88	0.87	0.81	0.19	0.09	-0.08	0.91	-0.78	-0.68	0.83	0.8	-0.03	-0.46	0.97	0.21	0.41	-0.69		0.91	-0.75	0.9	0.99	0.89	0.73
Non Current Liabilities Total	0.92	0.97	0.99	0.97	0.72	-0.12	0.36	0.08	0.95	-0.86	-0.55	0.89	0.7	-0.16	-0.59	0.93	0.55	0.62	-0.74	0.91		-0.74	0.85	0.92	0.98	0.91
Inventory	-0.6	-0.85	-0.78	-0.85	-0.43	0.18	-0.52	-0.43	-0.55	0.8	0.93	-0.62	-0.97	-0.49	-0.03	-0.87	-0.26	-0.74	0.74	-0.75	-0.74		-0.67	-0.81	-0.84	-0.78
Other Current Assets	0.97	0.87	0.8	0.85	0.94	0.29	-0.03	-0.28	0.85	-0.68	-0.65	0.86	0.72	0.01	-0.36	0.85	0.07	0.26	-0.54	0.9	0.85	-0.67		0.88	0.85	0.72
Other Stockholder Equity	0.9	0.93	0.91	0.9	0.74	0.06	0.23	0.06	0.9	-0.86	-0.71	0.79	0.83	-0.01	-0.45	0.99	0.29	0.53	-0.79	0.99	0.92	-0.81	0.88		0.92	0.75
Total Liab	0.88	1.0	0.99	1.0	0.67	-0.19	0.46	0.2	0.88	-0.91	-0.67	0.85	0.79	0.0	-0.46	0.95	0.53	0.71	-0.8	0.89	0.98	-0.84	0.85	0.92		0.93
Deferred Long Term Liab	0.74	0.92	0.92	0.95	0.58	-0.23	0.49	0.2	0.76	-0.75	-0.6	0.89	0.71	0.08	-0.34	0.81	0.59	0.69	-0.6	0.73	0.91	-0.78	0.72	0.75	0.93

Click cells to compare fundamentals

Hagerty Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Hagerty Stock Analysis

When running Hagerty's price analysis, check to measure Hagerty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hagerty is operating at the current time. Most of Hagerty's value examination focuses on studying past and present price action to predict the probability of Hagerty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hagerty's price. Additionally, you may evaluate how the addition of Hagerty to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Hagerty Research Development vs Tax Provision Analysis

Research Development vs Tax Provision

Research Development vs Tax Provision Correlation Analysis

Correlation Coefficient

Research Development

Tax Provision

Hagerty fundamental ratios Correlations

Hagerty Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Hagerty Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Assets
Total Liab	+ 1.0	Other Current Liab
Other Current Liab	+ 0.99	Total Assets
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.99	Short Long Term Debt Total
Other Stockholder Equity	+ 0.99	Other Assets

Cash	- 0.98	Net Debt
Inventory	- 0.97	Cash
Other Liab	- 0.93	Total Stockholder Equity
Total Liab	- 0.91	Current Deferred Revenue
Current Deferred Revenue	- 0.91	Short Long Term Debt Total
Current Deferred Revenue	- 0.91	Total Assets